Investigation announced for Long-Term Investors in Axsome
An investigation on behalf of investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares over potential wrongdoing.
Certain directors of Axsome Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Axsome Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
Axsome Therapeutics, Inc. (NASDAQ: AXSM) disclosed on August 9, 2021, that the FDA had found deficiencies with its New Drug Application (NDA) for AXS-05. The Company claimed it was attempting to determine the nature of the deficiencies, but that this announcement may delay the approval of AXS-05.
Shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) declined $74.10 per share on June 28, 2021, to as low as $19.38 per share on August 19, 2021.
Those who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North
San Diego, CA 92108
E-Mail: [email protected]
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.